Increased arterial stiffness in female-to-male transsexuals treated with androgen

Yayoi Emi, Miwa Adachi, Aiko Sasaki, Yoshio Nakamura, Mikiya Nakatsuka

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Aim: Female-to-male (FTM) transsexuals are treated with long-term and high-dose androgen. Although androgen is known to affect the cardiovascular system, vascular function in FTM transsexuals has not been fully elucidated. The aim of this study was to evaluate the arterial stiffness in FTM transsexuals treated with androgen. Methods: We evaluated the arterial stiffness in 111 FTM transsexuals (63 untreated FTM transsexuals and 48 FTM transsexuals treated with androgen) using a volume-plethysmographic apparatus equipped with a multi-element applanation tonometry sensor. Results: There were no significant differences in age, body mass index and heart rate between the untreated FTM transsexuals and those treated with androgen. The systolic and diastolic blood pressures in FTM transsexuals treated with androgen were significantly higher than those in untreated FTM transsexuals. The level of brachial-ankle pulse wave velocity in FTM transsexuals treated with androgen (1202.8 ± 138.2 cm/s) was significantly higher than that in untreated FTM transsexuals (1080.2 ± 113.7 cm/s) while there was no significant difference in the carotid augmentation index between untreated FTM transsexuals and those treated with androgen. Conclusions: Long-term and high-dose administration of androgen is likely to cause increased arterial stiffness in FTM transsexuals. To prevent atherosclerosis and cardiovascular events, a periodic checkup and pharmacological therapies for hypertension should be tailored on an individual basis.

Original languageEnglish
Pages (from-to)890-897
Number of pages8
JournalJournal of Obstetrics and Gynaecology Research
Volume34
Issue number5
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Vascular Stiffness
Androgens
Blood Pressure
Pulse Wave Analysis
Manometry
Cardiovascular System
Ankle
Blood Vessels
Atherosclerosis
Body Mass Index
Arm

Keywords

  • Androgen
  • Arterial stiffness
  • Plethysmography
  • Pulse wave velocity
  • Transsexuals

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Increased arterial stiffness in female-to-male transsexuals treated with androgen. / Emi, Yayoi; Adachi, Miwa; Sasaki, Aiko; Nakamura, Yoshio; Nakatsuka, Mikiya.

In: Journal of Obstetrics and Gynaecology Research, Vol. 34, No. 5, 10.2008, p. 890-897.

Research output: Contribution to journalArticle

Emi, Yayoi ; Adachi, Miwa ; Sasaki, Aiko ; Nakamura, Yoshio ; Nakatsuka, Mikiya. / Increased arterial stiffness in female-to-male transsexuals treated with androgen. In: Journal of Obstetrics and Gynaecology Research. 2008 ; Vol. 34, No. 5. pp. 890-897.
@article{9e1ff09932c14d8d99de8753b980f1f7,
title = "Increased arterial stiffness in female-to-male transsexuals treated with androgen",
abstract = "Aim: Female-to-male (FTM) transsexuals are treated with long-term and high-dose androgen. Although androgen is known to affect the cardiovascular system, vascular function in FTM transsexuals has not been fully elucidated. The aim of this study was to evaluate the arterial stiffness in FTM transsexuals treated with androgen. Methods: We evaluated the arterial stiffness in 111 FTM transsexuals (63 untreated FTM transsexuals and 48 FTM transsexuals treated with androgen) using a volume-plethysmographic apparatus equipped with a multi-element applanation tonometry sensor. Results: There were no significant differences in age, body mass index and heart rate between the untreated FTM transsexuals and those treated with androgen. The systolic and diastolic blood pressures in FTM transsexuals treated with androgen were significantly higher than those in untreated FTM transsexuals. The level of brachial-ankle pulse wave velocity in FTM transsexuals treated with androgen (1202.8 ± 138.2 cm/s) was significantly higher than that in untreated FTM transsexuals (1080.2 ± 113.7 cm/s) while there was no significant difference in the carotid augmentation index between untreated FTM transsexuals and those treated with androgen. Conclusions: Long-term and high-dose administration of androgen is likely to cause increased arterial stiffness in FTM transsexuals. To prevent atherosclerosis and cardiovascular events, a periodic checkup and pharmacological therapies for hypertension should be tailored on an individual basis.",
keywords = "Androgen, Arterial stiffness, Plethysmography, Pulse wave velocity, Transsexuals",
author = "Yayoi Emi and Miwa Adachi and Aiko Sasaki and Yoshio Nakamura and Mikiya Nakatsuka",
year = "2008",
month = "10",
doi = "10.1111/j.1447-0756.2008.00857.x",
language = "English",
volume = "34",
pages = "890--897",
journal = "Journal of Obstetrics and Gynaecology Research",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",
number = "5",

}

TY - JOUR

T1 - Increased arterial stiffness in female-to-male transsexuals treated with androgen

AU - Emi, Yayoi

AU - Adachi, Miwa

AU - Sasaki, Aiko

AU - Nakamura, Yoshio

AU - Nakatsuka, Mikiya

PY - 2008/10

Y1 - 2008/10

N2 - Aim: Female-to-male (FTM) transsexuals are treated with long-term and high-dose androgen. Although androgen is known to affect the cardiovascular system, vascular function in FTM transsexuals has not been fully elucidated. The aim of this study was to evaluate the arterial stiffness in FTM transsexuals treated with androgen. Methods: We evaluated the arterial stiffness in 111 FTM transsexuals (63 untreated FTM transsexuals and 48 FTM transsexuals treated with androgen) using a volume-plethysmographic apparatus equipped with a multi-element applanation tonometry sensor. Results: There were no significant differences in age, body mass index and heart rate between the untreated FTM transsexuals and those treated with androgen. The systolic and diastolic blood pressures in FTM transsexuals treated with androgen were significantly higher than those in untreated FTM transsexuals. The level of brachial-ankle pulse wave velocity in FTM transsexuals treated with androgen (1202.8 ± 138.2 cm/s) was significantly higher than that in untreated FTM transsexuals (1080.2 ± 113.7 cm/s) while there was no significant difference in the carotid augmentation index between untreated FTM transsexuals and those treated with androgen. Conclusions: Long-term and high-dose administration of androgen is likely to cause increased arterial stiffness in FTM transsexuals. To prevent atherosclerosis and cardiovascular events, a periodic checkup and pharmacological therapies for hypertension should be tailored on an individual basis.

AB - Aim: Female-to-male (FTM) transsexuals are treated with long-term and high-dose androgen. Although androgen is known to affect the cardiovascular system, vascular function in FTM transsexuals has not been fully elucidated. The aim of this study was to evaluate the arterial stiffness in FTM transsexuals treated with androgen. Methods: We evaluated the arterial stiffness in 111 FTM transsexuals (63 untreated FTM transsexuals and 48 FTM transsexuals treated with androgen) using a volume-plethysmographic apparatus equipped with a multi-element applanation tonometry sensor. Results: There were no significant differences in age, body mass index and heart rate between the untreated FTM transsexuals and those treated with androgen. The systolic and diastolic blood pressures in FTM transsexuals treated with androgen were significantly higher than those in untreated FTM transsexuals. The level of brachial-ankle pulse wave velocity in FTM transsexuals treated with androgen (1202.8 ± 138.2 cm/s) was significantly higher than that in untreated FTM transsexuals (1080.2 ± 113.7 cm/s) while there was no significant difference in the carotid augmentation index between untreated FTM transsexuals and those treated with androgen. Conclusions: Long-term and high-dose administration of androgen is likely to cause increased arterial stiffness in FTM transsexuals. To prevent atherosclerosis and cardiovascular events, a periodic checkup and pharmacological therapies for hypertension should be tailored on an individual basis.

KW - Androgen

KW - Arterial stiffness

KW - Plethysmography

KW - Pulse wave velocity

KW - Transsexuals

UR - http://www.scopus.com/inward/record.url?scp=52049120377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52049120377&partnerID=8YFLogxK

U2 - 10.1111/j.1447-0756.2008.00857.x

DO - 10.1111/j.1447-0756.2008.00857.x

M3 - Article

C2 - 18834347

AN - SCOPUS:52049120377

VL - 34

SP - 890

EP - 897

JO - Journal of Obstetrics and Gynaecology Research

JF - Journal of Obstetrics and Gynaecology Research

SN - 1341-8076

IS - 5

ER -